Vitamin D and Olive Polyphenol Composition for Bone Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone and cartilage disorders, such as osteoporosis and osteoarthritis, are limited in effectiveness, and there is a need for new compounds that can stimulate bone formation and inhibit bone resorption to address imbalances in bone metabolism and promote cartilage anabolism.
Innovation Solution
A combination of Vitamin D with hydroxytyrosol and oleuropein, derived from the olive tree, is used to potentiate the effects on bone formation and cartilage anabolism by stimulating osteoblast differentiation and activity, thereby enhancing bone growth and cartilage regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for bone and cartilage disorders are used, then bone formation stimulation and bone resorption inhibition are attempted, but the effectiveness is limited and insufficient to address imbalances in bone metabolism
Solution Approach 1:
The patent combines Vitamin D with hydroxytyrosol and oleuropein (polyphenols from olive tree) to create a synergistic composition. This merging of compounds with different mechanisms of action produces a more effective treatment than individual compounds alone, directly addressing the limited effectiveness of current single-agent therapies while simultaneously stimulating bone formation and inhibiting bone resorption.
Solution Approach 2:
The invention uses a composite composition comprising Vitamin D and polyphenolic compounds (hydroxytyrosol and/or oleuropein). This composite approach leverages the complementary properties of each component: Vitamin D for calcium metabolism and bone mineralization, and polyphenols for antioxidant protection and osteoblast stimulation, resulting in enhanced overall efficacy for treating bone and cartilage disorders.
2Reliability
If bone remodelling balance is disrupted in osteoporotic individuals, then bone loss occurs at a rapid rate, but the rate of bone formation remains insufficient to compensate
Solution Approach 1:
The synergistic combination of Vitamin D and polyphenols addresses both sides of the bone remodelling imbalance simultaneously. Vitamin D promotes calcium absorption and bone mineralization while polyphenols stimulate osteoblast activity and protect against oxidative stress, together restoring the balance between bone formation and resorption in osteoporotic conditions.
Solution Approach 2:
The composition changes the physiological parameters of bone metabolism by increasing osteoblast differentiation and activity, enhancing calcium absorption, and reducing osteoclast-mediated bone resorption. These parameter changes shift the bone remodelling balance toward net bone formation, compensating for the rapid bone loss characteristic of osteoporosis.
3Productivity
If existing active compounds for stimulating bone formation are used, then some bone formation stimulation is achieved, but the success rate remains limited and new compounds are constantly needed
Solution Approach 1:
The patent employs a composite therapeutic approach combining Vitamin D (which regulates calcium-phosphate metabolism and promotes osteoblast differentiation) with polyphenolic compounds (which provide antioxidant protection and stimulate osteoblast activity). This composite formulation achieves superior bone formation stimulation and treatment success rates compared to existing single-compound therapies, reducing the need for constant development of new compounds.
Data Source
AI summary
The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders.